Efficacy and safety of eslicarbazepine acetate as therapy in patients with fibromyalgia: A double-blind, randomised, placebo-controlled, parallel-group, multicentre clinical trial.
Phase of Trial: Phase II
Latest Information Update: 01 Mar 2017
At a glance
- Drugs Eslicarbazepine acetate (Primary)
- Indications Fibromyalgia
- Focus Therapeutic Use
- Sponsors Bial
- 03 May 2014 Tolerability results from a pooled analysis of 5 trials in elderly patients who participated in non-epilepsy studies presented at the 66th Annual Meeting of the American Academy of Neurology.
- 28 Mar 2013 New source identified and integrated (ClinicalTrials.gov: US National Institutes of Health: NCT01820585).
- 28 Jun 2012 Planned number of patients changed from 480 to 750 as reported by EudraCT.